is mounjaro a glp-1 medicine vs. Ozempic: What's the Difference Weight Loss Injection/ GLP-1 |

Regarding co-agonist treatment, tirzepatide was recently shown in a post hoc analysis of the SURMOUNT-1 trial to also reduce UACR in overweight/obese people without T2D (88), and similar benefits for kidney function were shown in subjects with heart failure (89)

However, their use must be balanced against significant considerations including safety concerns, high costs, and the need for comprehensive monitoring and support

These options might include linking payments to patient outcomes, risk-sharing with manufacturers, or tiered formularies that promote cost-effective medications

Key benefits of IV therapy for GLP-1 users include: Restores hydration quickly Improves energy levels Supports metabolism Reduces fatigue Helps maintain nutrient balance Supports fat-burning processes Unlike oral supplements, IV therapy offers immediate absorption and faster results